Cargando…

Development of Monoclonal Antibodies and Antigen-Capture ELISA for Human Parechovirus Type 3

Human parechovirus type 3 (HPeV3) is an etiologic agent of respiratory diseases, meningitis, and sepsis-like illness in both infants and adults. Monoclonal antibodies (mAbs) can be a promising diagnostic tool for antigenic diseases such as virus infection, as they offer a high specificity toward a s...

Descripción completa

Detalles Bibliográficos
Autores principales: Goto, Keiko, Yamaoka, Yutaro, Khatun, Hajera, Miyakawa, Kei, Nishi, Mayuko, Nagata, Noriko, Yanaoka, Toshikazu, Kimura, Hirokazu, Ryo, Akihide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563955/
https://www.ncbi.nlm.nih.gov/pubmed/32961740
http://dx.doi.org/10.3390/microorganisms8091437
_version_ 1783595604895596544
author Goto, Keiko
Yamaoka, Yutaro
Khatun, Hajera
Miyakawa, Kei
Nishi, Mayuko
Nagata, Noriko
Yanaoka, Toshikazu
Kimura, Hirokazu
Ryo, Akihide
author_facet Goto, Keiko
Yamaoka, Yutaro
Khatun, Hajera
Miyakawa, Kei
Nishi, Mayuko
Nagata, Noriko
Yanaoka, Toshikazu
Kimura, Hirokazu
Ryo, Akihide
author_sort Goto, Keiko
collection PubMed
description Human parechovirus type 3 (HPeV3) is an etiologic agent of respiratory diseases, meningitis, and sepsis-like illness in both infants and adults. Monoclonal antibodies (mAbs) can be a promising diagnostic tool for antigenic diseases such as virus infection, as they offer a high specificity toward a specific viral antigen. However, to date, there is no specific mAb available for the diagnosis of HPeV3 infection. In this study, we developed and characterized mAbs specific for HPeV3 capsid protein VP0. We used cell-free, wheat germ-synthesized viral VP0 protein for immunizing BALB/c mice to generate hybridomas. From the resultant hybridoma clones, we selected nine clones producing mAbs reactive to the HPeV3-VP0 antigen, based on enzyme-linked immunosorbent assay (ELISA). Epitope mapping showed that these mAbs recognized three distinct domains in HPeV3 VP0. Six mAbs recognized HPeV3 specifically and the other three mAbs showed cross-reactivity with other HPeVs. Using the HPeV3-specific mAbs, we then developed an ELISA for viral antigen detection that could be reliably used for laboratory diagnosis of HPeV3. This ELISA system exhibited no cross-reactivity with other related viruses. Our newly developed mAbs would, thus, provide a useful set of tools for future research and ensure HPeV3-specific diagnosis.
format Online
Article
Text
id pubmed-7563955
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-75639552020-10-27 Development of Monoclonal Antibodies and Antigen-Capture ELISA for Human Parechovirus Type 3 Goto, Keiko Yamaoka, Yutaro Khatun, Hajera Miyakawa, Kei Nishi, Mayuko Nagata, Noriko Yanaoka, Toshikazu Kimura, Hirokazu Ryo, Akihide Microorganisms Article Human parechovirus type 3 (HPeV3) is an etiologic agent of respiratory diseases, meningitis, and sepsis-like illness in both infants and adults. Monoclonal antibodies (mAbs) can be a promising diagnostic tool for antigenic diseases such as virus infection, as they offer a high specificity toward a specific viral antigen. However, to date, there is no specific mAb available for the diagnosis of HPeV3 infection. In this study, we developed and characterized mAbs specific for HPeV3 capsid protein VP0. We used cell-free, wheat germ-synthesized viral VP0 protein for immunizing BALB/c mice to generate hybridomas. From the resultant hybridoma clones, we selected nine clones producing mAbs reactive to the HPeV3-VP0 antigen, based on enzyme-linked immunosorbent assay (ELISA). Epitope mapping showed that these mAbs recognized three distinct domains in HPeV3 VP0. Six mAbs recognized HPeV3 specifically and the other three mAbs showed cross-reactivity with other HPeVs. Using the HPeV3-specific mAbs, we then developed an ELISA for viral antigen detection that could be reliably used for laboratory diagnosis of HPeV3. This ELISA system exhibited no cross-reactivity with other related viruses. Our newly developed mAbs would, thus, provide a useful set of tools for future research and ensure HPeV3-specific diagnosis. MDPI 2020-09-19 /pmc/articles/PMC7563955/ /pubmed/32961740 http://dx.doi.org/10.3390/microorganisms8091437 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Goto, Keiko
Yamaoka, Yutaro
Khatun, Hajera
Miyakawa, Kei
Nishi, Mayuko
Nagata, Noriko
Yanaoka, Toshikazu
Kimura, Hirokazu
Ryo, Akihide
Development of Monoclonal Antibodies and Antigen-Capture ELISA for Human Parechovirus Type 3
title Development of Monoclonal Antibodies and Antigen-Capture ELISA for Human Parechovirus Type 3
title_full Development of Monoclonal Antibodies and Antigen-Capture ELISA for Human Parechovirus Type 3
title_fullStr Development of Monoclonal Antibodies and Antigen-Capture ELISA for Human Parechovirus Type 3
title_full_unstemmed Development of Monoclonal Antibodies and Antigen-Capture ELISA for Human Parechovirus Type 3
title_short Development of Monoclonal Antibodies and Antigen-Capture ELISA for Human Parechovirus Type 3
title_sort development of monoclonal antibodies and antigen-capture elisa for human parechovirus type 3
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563955/
https://www.ncbi.nlm.nih.gov/pubmed/32961740
http://dx.doi.org/10.3390/microorganisms8091437
work_keys_str_mv AT gotokeiko developmentofmonoclonalantibodiesandantigencaptureelisaforhumanparechovirustype3
AT yamaokayutaro developmentofmonoclonalantibodiesandantigencaptureelisaforhumanparechovirustype3
AT khatunhajera developmentofmonoclonalantibodiesandantigencaptureelisaforhumanparechovirustype3
AT miyakawakei developmentofmonoclonalantibodiesandantigencaptureelisaforhumanparechovirustype3
AT nishimayuko developmentofmonoclonalantibodiesandantigencaptureelisaforhumanparechovirustype3
AT nagatanoriko developmentofmonoclonalantibodiesandantigencaptureelisaforhumanparechovirustype3
AT yanaokatoshikazu developmentofmonoclonalantibodiesandantigencaptureelisaforhumanparechovirustype3
AT kimurahirokazu developmentofmonoclonalantibodiesandantigencaptureelisaforhumanparechovirustype3
AT ryoakihide developmentofmonoclonalantibodiesandantigencaptureelisaforhumanparechovirustype3